PharmaTelevision - John Noble, Director, British Brands Group talks about the powerful economic force of branding and the importance of branding to the pharmaceutical industry

John Noble, Director, British Brands Group talks about the powerful economic force of branding and the importance of branding to the pharmaceutical industry

Episode Loading...

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: John Noble, Director, British Brands Group talks about the powerful economic force of branding and the importance of branding to the pharmaceutical industry

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to John Noble, Director of British Brands Group

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

British Brands Group: Aim and purpose

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at the LESI Conference in London 2011. On this show I have John Noble, who is a Director of the British Brands Group, welcome to the show.

John Noble:

Thank you very much.

Fintan Walton:

British Brands Group as I understand it is a not for profit organization whose purpose is to try and help UK based companies to develop brands, is that correct?

John Noble:

Yes it is, I mean I think our work is in many ways broader than that I mean yes we are a membership organization and currently a corporate membership organization rather than for individuals and what the group does is speak on behalf of brand owners and particularly brands manufacturers to policy makers in the UK to try and shape a policy framework in the UK that creates you know that is positive for the creation and building of brands and branded companies. So that policymakers understand just how important brands are to consumers more certainly, but also it is society and in the current times particularly to the economy because often you know this brands and their interests are represented people may take it for granted people may not think about the brand dimension when formulating policy so we make sure that doesn't happen and that the true value of brands comes across to the policy makers.

Fintan Walton:

Okay so you're not efficacy group and some guys I suppose?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

John Noble

Director

John Noble is Director of the British Brands Group, a membership organization that provides the collective voice for brand manufacturers in the UK. The Group was founded in 1994 to promote the values and benefits of brands to consumers, the economy, and society, as well as to represent brand manufacturers on policy issues. Through its lectures, research studies, conferences, publications and briefings, the British Brands Group is committed to deepening understanding amongst those who make and shape public policy of the contribution of brands to the quality of our everyday lives and the success of the economy. It is part of network of similar organizations across Europe and represents AIM, the European Brands Association, in the UK. John Noble is a Chartered Marketer and, prior to joining the British Brands Group, followed a marketing career that started with British Airways before moving into marketing consultancy with Marketing Solutions. He then became Head of Marketing for Hamptons, the firm of estate agents, and held a senior marketing role with Bristol & West International.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

British Brands Group

British Brands Group founded in 1994, is a non-profit-making membership organization. Its role is to speak out authoritatively on behalf of brands and to represent them collectively when commercial and regulatory issues threaten both their value and their ability to be a positive force in society. While the Group's work focuses primarily on UK policy makers, it also seeks to deepen understanding of how brands benefit consumers, society and the economy by delivering choice, value for money and innovation to consumers. The Group also provides the prime forum for its members on brand-related issues. British Brands Group is part of a global network of similar brand associations, and is the UK representative of AIM, the European Brands Association, based in Brussels.